The conception of vascular insufficiency was introduced by Corday and his coworkers is 1953 as an expression of disease-unit such as cerebral vascular insufficiency. This is a clinical unit which is assumed to be caused by localized and transient cerebral circulatory disturbance.
As the anatomical background, they referred to the works of Hicks et al. that there was no mechanical obstruction in the cerebral vessels in more than a half of autopsy cases of cerebral softening. These aspects of cerebral circulatory impairment were also detailed by Bailey in the term of transient cerebral ischemia without infarction.
In 1959, Prof. Maekawa postulated that the pathogenesis of functional and organic vascular diseases in the brain, heart and probably kidneys would be identically comprehend with the conception of vascular insufficiency, namely angina pectoris corresponds to cerebral vascular insufficiency and myocardial infarction to cerebral softening. The development of these disorders is closely related not only with arteriosclerotic and thrombotic process in the organs but also with a decrease in "Windkessel Funktion " due to aortic sclerosis. Clinically the difference between these functional and organic disease is not of quality but of only quantity.
Here the anticoagulant treatment for vascular insufficiency must be considered.
The purpose of this report is to show the result of anticoagulant treatment which we have experienced since 1950 with special reference to vascular insufficiency.
The patients treated with anticoagulants have been so far 120 in total in our clinic, i.e., 55 cases of cerebral diseases, 54 of cardiac diseases, 9 of obstructive thromboangitis and 2 of other diseases. The patients with cerebral diseases consist of ll cases of cerebral vascular insufficiency, 20 of cerebral softening and 24 of cerebral embolism. In most cases, the administration of anticoagulants has been limited to some period of hospitalization, but in some cases, it has still been continued even after discharge.
Result and Discussion

I. Cerebral
Vascular Insufficiency and Cerebral Softening The differentiation of cerebral vascular insufficiency from cerebral softening was mainly made according to the descriptions by Bailey and Millikan ; the final determination was made by observing the course of disease. However, both of them may reasonably be approached as a unit of disease, therefore the term obstructive cerebral vascular disease was tentatively used to include both of them in this study.
The patients studied was 70 in total including controls ; among patients with cerebral vascular insufficiency, ll were treated with anticoagulant drugs and 24 served as controls, and among those with cerebral softening, 20 were treated with anticoagulant therapy and 15 served as controls.
The administration-period of anticoagulants ranged from 8 days to 2 years and 5 months (average: 7.2 months).
When the cerebral lesions were classified from the viewpoint of the vertebrobasilar artery system and carotid artery system, the cerebral vascular insufficiency was more frequently seen in the vertebro-basilar system, and the cerebral softening, in the carotid artery system. The controls, especially those with cerebral vascular insufficiency, were found to be more frequently complicated by hypertension.
Our patients so far stud- Hayase Jap. J. Med. 1963 ied are chronologically shown in Table 1 , in which controlling is combination of control-in-series and in-parallel. i ) The frequency of cerebrovascular episodes during treatment and non-treatment
In 31 treated cases no attack was seen during medication, while transient or apoplectic episodes had been seen over 56 times prior to the administration of anticoagulants. In 39 controls, the episodes amounted to 75 times. These results appear to suggest a certain prophylactic effect of anticoagulant drugs on cerebrovascular strokes. But it should be kept in mind that the application of the drugs was mostly made under the circumstances of hospitalization, while the frequency of the episode above mentioned was mostly counted in the out-patient clinic or in arbitrary active life of patients. Therefore, these figures may not serve as appropriate controls. i i ) The frequency of cerebrovascular attack during hospitalization In order to makea fair comparisonbetweenthe treated and control group, the frequency of cerebrovascular attack was compared only regarding the periods of hospitalization of these groups.
In the cases, the period of hospitalization before anticoagulant administration was assumed to be a control period. As shown in Table 2 , on Even when we take account of the fact that the period of observation was not equal between them and that the complication of hypertension was more frequently seen in the controls, certain prophylactic effect of anticoagulants on cerebrovascular strokes could be recognized.
iii) The cases of cerebrovascular attacks during hospitalization All the attacks experienced during hospitalization were relapses for the patients except one with hypertension : one of them showed repeated attacks of cerebral vascular insufficiency; other one, a cerebral softening developed from a vascular insufficiency; 3 of them, a cerebral softening plus episodes of vascular insufficiency ; and the remaining 3, relapses of cerebral softening.
In these patients, the time interval between attacks before and after admission was relatively short, and this fact may show that when attacks are repeated, the time interval between them is usually short and some early treatment is required. These values of the prothromin time may be assumed to be below or the lower limit of so far proposed therapeutic range and may draw some criticism.
These values, however, have been proposed by Prof. Maekawa as appropriate one for the treatment of cerebral vascular diseases from the view-point of the followings : 1. the brain vessels are not so sufficiently protected by the peri-vascular tissues as the heart vessels; 2. smaller doses of anticoagulant would be sufficient to inhibit the growth of thrombi so as to keep and develope the collateral circulation.
II. Angina Pectoris Angina pectoris first described by Heberden is a functional disease which has various basic disorders and pathophysiological conditions, and it has been classified into several types, i.e., angina of effort, at rest, decubitus and vasomotorica.
The anginal patients who have had anticoagulant treatement in our clinic are as follows. Case 1 had typical symptoms of angina of effort and has received continuous anticoagulant treatment for 2 years and 3 months during hospitalization and after discharge.
In so far as the frequency of anginal attack is concerned, no effect has been seen with anticoagulants. Case 2 was hospitalized because of repeated attacks of angina of effort and cardiac failure and died 2 weeks later. The effect of anticoagulant treatment was obscure. Case 3 was hospitalized because of angina vasomotorica and later an attack of myocardial infarction.
Since then anticoagulant treatment has been continued, but no effect has been seen on the frequency of anginal symptoms.
In 6 other patients with angina pectoris vasomotorica and/or atypical angina, we have administered anticoagulant drugs for 2 weeks to 2 years and 2 months. In these patients, however, adrenocortical hormones, chlorothiazide, etc. have been rather effective to prevent anginal attacks.
The doses of anticoagulants were controlled so as to keep prothrombin time from 22 to 35 seconds (prothrombin activity, 18-40%).
In order to evaluate the effect of anticoagulant treatment on angina pectoris, we still have been lacking in sufficient number of experiences.
When the administration of anticoagulants and the evaluation of its effect are considered, it would be necessary to clarify the type of anginal attack.
III. Renal Vascular Insufficiency
The renal vascular insufficiency is considered as a clinical entity 1. The doses of anticoagulants were controlled so as to keep the prothrombin time from 22 to 35 seconds (prothrombin activity, 18-40%) in the cases of angina pectoris and thromboaortitis, and at about 20 seconds (prothrombin activity, 45%) in the cases of occlusive cerebral vascular disease.
2. The treatment period has numbered 98 months in 31 cases of occlusive cerebral vascular diseases (ll of cerebral vascular insufficiency and 20 of cerebral softening) and the control period has numbered 191 months without anticoagulant treatment.
There has been no cerebral attack in the former but 9 attacks in the latter.
3. The effect of anticoagulant treatment on angina pectoris appears to be obscure. To relieve anginal symptoms, other treatments for the basic ot complicated diseases appear to be more important.
4. The symptoms and impaired renal clearance in the patients with obstructive thromboaortitis have tended to be ameliorated.
Although the indication of anticoagulant treatment and its effect on cerebral vascular insufficiency, angina pectoris and renal vascular insufficiency have partly clarified in this report, the final conclusion needs to wait further well-controlled and long-term studies.
